共 50 条
- [1] OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse [J]. The Journal of Headache and Pain, 2013, 14
- [2] OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
- [5] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache [J]. The Journal of Headache and Pain, 2013, 14
- [6] Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
- [7] The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
- [8] The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study [J]. The Journal of Headache and Pain, 2020, 21
- [10] Botulinum toxin type A in the treatment of chronic migraine without medication overuse [J]. HEADACHE, 2008, 48 (02): : 201 - 209